Crescent Biopharma (CBIO) Net Cash Flow (QoQ) (2013 - 2026)
Crescent Biopharma (CBIO) Net Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Crescent Biopharma |
486.92 Mn |
297.76 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-130.01% |
| Dec 31, 2025 |
513.61% |
| Sep 30, 2025 |
-114.84% |
| Jun 30, 2025 |
1,155.97% |
| Mar 31, 2025 |
-135.49% |
| Jun 30, 2024 |
15.37% |
| Mar 31, 2024 |
-38.04% |
| Dec 31, 2023 |
11.76% |
| Sep 30, 2023 |
-23.89% |
| Jun 30, 2023 |
-140.66% |
| Mar 31, 2023 |
316.54% |
| Dec 31, 2022 |
8.21% |
| Sep 30, 2022 |
47.03% |
| Jun 30, 2022 |
-18.44% |
| Mar 31, 2022 |
-17.73% |
| Dec 31, 2021 |
31.07% |
| Sep 30, 2021 |
-24.33% |
| Jun 30, 2021 |
-198.32% |
| Mar 31, 2021 |
21.78% |
| Dec 31, 2020 |
16.33% |
